Long-term follow-up of the comparison of an operation to monitoring, with option of endocrine therapy (comet) study
Active Project Grant Awarded Last action
- Award ID
- HT9425261E018
- Recipient
-
Duke University UEI F5KMGCBTML55
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $3,820,095
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 8% complete
- Place of performance
- Durham, NC 27708, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Duke University $3.82 million on July 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct the long-term follow-up of the COMET (Comparison of an Operation to Monitoring, with Option of Endocrine Therapy) study through June 30, 2030. The award is classified as a Project Grant and obligates $3,820,095.
Work is performed in Durham, North Carolina. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research, including investigation of medical solutions for battlefield contexts. Awards under this program typically span three to four years and range from $100,000 to $20 million for consortium efforts, depending on funding priorities and project scope.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Leland Stanford Junior University | $308,000 |
Quick answers
Who received award HT9425261E018?
HT9425261E018 was awarded to Duke University by Defense Health Agency (Department of Defense) on July 1, 2026.
How much is award HT9425261E018 worth?
$3,820,095 has been obligated on HT9425261E018.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award